SIRT2 is a tumor suppressor that connects aging, acetylome, cell cycle signaling, and carcinogenesis
- PMID: 22943040
- PMCID: PMC3431025
SIRT2 is a tumor suppressor that connects aging, acetylome, cell cycle signaling, and carcinogenesis
Abstract
One long standing observation in clinical oncology is that age increase is the single most statistically significant factor/variable that predicts for the incidence of solid tumors. This observation suggests that the cellular and molecular processes and mechanisms that direct an organism's life span may be used to determine the clinical connection between aging and carcinogenesis. In this regard, the genes that impact upon longevity have been characterized in S. cerevisiae and C. elegans, and the human homologs include the Sirtuin family of protein deacetylases. We have recently shown that the primary cytoplasmic sirtuin, Sirt2 appears to meet the criteria as a legitimate tumor suppressor protein. Mice genetically altered to delete Sirt2 develop gender-specific tumorigenesis, with females primarily developing mammary tumors, and males developing multiple different types of gastrointestinal malignancies. Furthermore human tumors, as compared to normal samples, displayed significant decreases in SIRT2 levels suggesting that SIRT2 may also be a human tumor suppressor.
Conflict of interest statement
Figures
Similar articles
-
The Clinical Significance of SIRT2 in Malignancies: A Tumor Suppressor or an Oncogene?Front Oncol. 2020 Sep 8;10:1721. doi: 10.3389/fonc.2020.01721. eCollection 2020. Front Oncol. 2020. PMID: 33014852 Free PMC article. Review.
-
FISH-mapping and genomic organization of the NAD-dependent histone deacetylase gene, Sirtuin 2 (Sirt2).Int J Oncol. 2005 Nov;27(5):1187-96. Int J Oncol. 2005. PMID: 16211212
-
Emerging role of SIRT2 in non-small cell lung cancer.Oncol Lett. 2021 Oct;22(4):731. doi: 10.3892/ol.2021.12992. Epub 2021 Aug 11. Oncol Lett. 2021. PMID: 34429771 Free PMC article. Review.
-
Loss of NAD-Dependent Protein Deacetylase Sirtuin-2 Alters Mitochondrial Protein Acetylation and Dysregulates Mitophagy.Antioxid Redox Signal. 2017 May 20;26(15):849-863. doi: 10.1089/ars.2016.6662. Epub 2016 Sep 8. Antioxid Redox Signal. 2017. PMID: 27460777 Free PMC article.
-
Acetylation of Sirt2 by p300 attenuates its deacetylase activity.Biochem Biophys Res Commun. 2008 Oct 31;375(4):576-80. doi: 10.1016/j.bbrc.2008.08.042. Epub 2008 Aug 21. Biochem Biophys Res Commun. 2008. PMID: 18722353
Cited by
-
B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2.Cell Death Dis. 2019 Apr 5;10(4):308. doi: 10.1038/s41419-019-1549-6. Cell Death Dis. 2019. PMID: 30952834 Free PMC article.
-
Sirt2 deacetylase is a novel AKT binding partner critical for AKT activation by insulin.J Biol Chem. 2014 Feb 28;289(9):6054-66. doi: 10.1074/jbc.M113.537266. Epub 2014 Jan 20. J Biol Chem. 2014. PMID: 24446434 Free PMC article.
-
Overexpression of SASH1 related to the decreased invasion ability of human glioma U251 cells.Tumour Biol. 2012 Dec;33(6):2255-63. doi: 10.1007/s13277-012-0487-z. Epub 2012 Aug 23. Tumour Biol. 2012. PMID: 22915266
-
SIRT2-Mediated Deacetylation and Tetramerization of Pyruvate Kinase Directs Glycolysis and Tumor Growth.Cancer Res. 2016 Jul 1;76(13):3802-12. doi: 10.1158/0008-5472.CAN-15-2498. Epub 2016 Apr 27. Cancer Res. 2016. PMID: 27197174 Free PMC article.
-
Inactivation of Sirtuin2 protects mice from acetaminophen-induced liver injury: possible involvement of ER stress and S6K1 activation.BMB Rep. 2019 Mar;52(3):190-195. doi: 10.5483/BMBRep.2019.52.3.083. BMB Rep. 2019. PMID: 30021675 Free PMC article.
References
-
- Bishop JM. Viral oncogenes. Cell. 1985;42:23–38. - PubMed
-
- Gius D, Cui H, Bradbury CM, et al. Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. Cancer Cell. 2004;6:361–71. - PubMed
-
- Sherr CJ, McCormick F. The RB and p53 pathways in cancer. Cancer Cell. 2002;2:103–12. - PubMed
-
- Hunter T. Oncoprotein networks. Cell. 1997;88:333–46. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases